Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Haldol decanoate cost?

See the DrugPatentWatch profile for Haldol

Haldol decanoate is an injectable antipsychotic medication used to treat chronic psychotic disorders like schizophrenia. Its cost can vary significantly depending on factors such as dosage, quantity, insurance coverage, and the specific pharmacy or healthcare provider.

How much does a typical dose of Haldol decanoate cost?


The price for a single vial or injection of Haldol decanoate can range from approximately \$20 to over \$100. This price can be influenced by the concentration of the drug (e.g., 50 mg/mL or 100 mg/mL) and the volume of the vial. For instance, a 1 mL vial of 50 mg/mL might cost differently than a 5 mL vial of 100 mg/mL.

What factors influence the price of Haldol decanoate?


Several elements contribute to the final cost of Haldol decanoate. Insurance plans often play a substantial role, with copays and deductibles determining out-of-pocket expenses for patients. Generic availability also impacts pricing, as generic versions typically are less expensive than their brand-name counterparts. Pharmacies may also have different pricing structures, and bulk purchasing by healthcare facilities can lead to lower per-unit costs. Information on drug pricing and patent expiration dates can be found on DrugPatentWatch.com [1].

Are there cost-saving options for Haldol decanoate?


Patients may explore several avenues to reduce the cost of Haldol decanoate. Checking with insurance providers for coverage details and potential preferred pharmacies can be a first step. Inquiring about the availability of generic formulations, which are usually more affordable, is also advisable. Some pharmaceutical manufacturers offer patient assistance programs that can provide discounts or free medication for eligible individuals who meet specific income or insurance criteria. Comparing prices at different pharmacies can also yield savings.

When does patent exclusivity for Haldol decanoate expire?


The patent exclusivity for Haldol decanoate, also known by its active ingredient haloperidol decanoate, has largely expired. This has allowed for the availability of generic versions of the medication. DrugPatentWatch.com tracks patent information for various drugs, including those related to antipsychotics [1].

How does Haldol decanoate compare in price to other long-acting antipsychotics?


Compared to other long-acting injectable antipsychotics, Haldol decanoate is often considered one of the more affordable options, particularly its generic forms. However, newer long-acting injectables with different mechanisms of action or extended dosing intervals (e.g., monthly or every few months) may have higher price points. The cost-effectiveness also depends on treatment adherence and the reduction in hospitalizations or other costly interventions that long-acting formulations can provide.

Sources:
[1] https://drugpatentwatch.com/



Other Questions About Haldol :

Haldol vs zyprexa? Haldol online pharmacy? How often can haldol be given? Buy haldol bulk? Haldol class? Generic haldol coupon? Haldol injection?

AI-Drug Label Prescribing Information Alignment Report

20
20%
Grade F

Unsafe

Mostly Unaligned

Patient Risk: Low

Summary

The provided label excerpts address increased mortality in elderly patients with dementia-related psychosis and that Haldol decanoate is not approved for that indication. The AI claims provided are largely about pricing and general use (e.g., chronic psychotic disorders like schizophrenia) and do not have support within the supplied label text; they therefore cannot be verified against the provided prescribing information.


Category Scores

Indication
20
Poor
Warnings
40
Poor
SpecificPopulations
60
Good

Accurate Statements

Haldol decanoate is not approved for the treatment of patients with dementia-related psychosis (increased mortality warning in elderly patients with dementia-related psychosis).
Supported by provided label sections 5.1 and 8.5: "HALDOL DECANOATE is not approved for the treatment of patients with dementia-related psychosis."

Unsupported Statements

Haldol decanoate is used to treat chronic psychotic disorders like schizophrenia.
The supplied label excerpts (5.1 and 8.5) only discuss increased mortality in elderly patients with dementia-related psychosis and the product not being approved for that indication; no indication statement supporting schizophrenia/chronic psychotic disorders is included.
The price for a single vial or injection of Haldol decanoate can range from approximately $20 to over $100.
Pricing information is not present in the supplied label excerpts.
The price of Haldol decanoate can be influenced by the concentration of the drug (e.g., 50 mg/mL or 100 mg/mL).
No pricing or concentration-related pricing factors are present in the supplied label excerpts.
The price of Haldol decanoate can be influenced by the volume of the vial.
No pricing or vial-volume pricing factors are present in the supplied label excerpts.
Insurance plans can influence out-of-pocket expenses for Haldol decanoate via copays and deductibles.
No insurance/copay/deductible content is present in the supplied label excerpts.
Generic availability impacts pricing for Haldol decanoate, as generic versions are typically less expensive than brand-name counterparts.
No pricing or generic-versus-brand pricing content is present in the supplied label excerpts.
Pharmacies may have different pricing structures for Haldol decanoate.
No pharmacy pricing content is present in the supplied label excerpts.
Bulk purchasing by healthcare facilities can lead to lower per-unit costs of Haldol decanoate.
No bulk purchasing/pricing content is present in the supplied label excerpts.
Patent exclusivity for Haldol decanoate has largely expired.
No patent/exclusivity content is present in the supplied label excerpts.
Because patent exclusivity for Haldol decanoate has largely expired, generic versions of the medication are available.
No patent/generic availability content is present in the supplied label excerpts.
Compared to other long-acting injectable antipsychotics, Haldol decanoate is often considered one of the more affordable options, particularly its generic forms.
No comparative affordability/pricing content is present in the supplied label excerpts.
Newer long-acting injectables with different mechanisms of action or extended dosing intervals may have higher price points than Haldol decanoate.
No comparative pricing or product class pricing content is present in the supplied label excerpts.
The cost-effectiveness of long-acting formulations depends on treatment adherence and the reduction in hospitalizations or other costly interventions.
No health-economics/cost-effectiveness statements are present in the supplied label excerpts.

Contradictions


Important Omissions

Any label-supported dosing and administration details for the product.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
The only clearly label-supported safety-related point in the provided material is the increased mortality warning in elderly patients with dementia-related psychosis and the statement that Haldol decanoate is not approved for that indication. However, most other claims are unsupported by the supplied label excerpts and therefore cannot be considered label-accurate.

Regulatory Assessment

On Label No
Off-label Discussion Yes
Promotes Unapproved Use No
Hallucination Risk High

Recommendation

Mostly Unaligned

Primary Issue
Most claims (especially pricing, patent/generic, and schizophrenia/chronic psychotic disorder use) are not supported by the supplied FDA label excerpts.

Suggested Improvement
Limit statements to what is present in the provided label text (increased mortality in elderly patients with dementia-related psychosis; not approved for that indication). Remove or replace unsupported pricing/patent/comparative affordability claims, and provide label excerpts for indications/dosing if those are to be evaluated.

Drug Brand Mention Assessment

Branding Score
54
Visibility
66
Mentioned
Ranking
#1
Sentiment
65
Recommendation Status
strong alternative
Brand Perception
Best Known For

injectable antipsychotic medication used to treat chronic psychotic disorders like schizophrenia


Core Claims
  • Haldol decanoate is an injectable antipsychotic medication used to treat chronic psychotic disorders like schizophrenia.
  • The price for a single vial or injection of Haldol decanoate can range from approximately $20 to over $100.
  • Generic availability typically makes pricing less expensive than brand-name counterparts.
  • Haldol decanoate has largely expired patent exclusivity, allowing availability of generic versions.
  • Compared to other long-acting injectable antipsychotics, Haldol decanoate is often considered one of the more affordable options, particularly its generic forms.
Differentiators
  • Often considered one of the more affordable options, particularly its generic forms.
  • Patent exclusivity has largely expired, enabling generic availability.
  • Price varies based on concentration (e.g., 50 mg/mL or 100 mg/mL) and vial volume.

Pricing Perception: Mid Range
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
DrugPatentWatch 4%
50 #3 No